GH Research (GHRS) Research & Development (2020 - 2025)
GH Research's (GHRS) quarterly Research & Development came in at -$66.1 million in Q4 2025, down 6.98% year-on-year from -$71.1 million in Q4 2024, and down 725.93% quarter-over-quarter from $10.6 million in Q3 2025.
GH Research (GHRS) Research & Development (2020 - 2025) Analysis & Trends
GH Research's Research & Development history runs 6 years deep, the most recent figure standing at -$66.1 million for Q4 2025.
- On a quarterly basis, Research & Development fell 6.98% year-over-year to -$66.1 million in Q4 2025; TTM through Dec 2025 was -$38.8 million, a 10.71% decrease from a year earlier, with the FY2025 full-year figure at -$38.8 million, down 10.71% from the prior year.
- Research & Development slipped to -$66.1 million in Q4 2025 per GHRS's latest filing, from $10.6 million in the prior quarter.
- Across five years, Research & Development topped out at $13.8 million in Q4 2021 and bottomed at -$66.1 million in Q4 2025.
- The 5-year median for Research & Development is $7.1 million (2023), against an average of -$1.2 million.
- Biggest YoY gain for Research & Development was 3004.97% in 2021; the steepest drop was 4547.27% in 2021.
- Year by year, Research & Development stood at $13.8 million in 2021, then tumbled by 49.76% to $6.9 million in 2022, then gained by 19.41% to $8.3 million in 2023, then tumbled by 849.32% to -$61.8 million in 2024, then dropped by 6.98% to -$66.1 million in 2025.
- Per Business Quant, the three latest GHRS Research & Development figures stand at -$66.1 million (Q4 2025), $10.6 million (Q3 2025), and $9.0 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | GH Research | 1.65 Bn | 1.65 Bn | - | -66.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -66.14 Mn |
| Sep 30, 2025 | 10.57 Mn |
| Jun 30, 2025 | 8.96 Mn |
| Mar 31, 2025 | 7.85 Mn |
| Dec 31, 2024 | -61.83 Mn |
| Sep 30, 2024 | 8.40 Mn |
| Jun 30, 2024 | 9.76 Mn |
| Mar 31, 2024 | 8.66 Mn |
| Dec 31, 2023 | 8.25 Mn |
| Sep 30, 2023 | 7.09 Mn |
| Jun 30, 2023 | 7.18 Mn |
| Mar 31, 2023 | 7.31 Mn |
| Dec 31, 2022 | 6.91 Mn |
| Sep 30, 2022 | 4.62 Mn |
| Jun 30, 2022 | 4.24 Mn |
| Mar 31, 2022 | -4.71 Mn |
| Dec 31, 2021 | 13.76 Mn |
| Sep 30, 2021 | -2.56 Mn |
| Jun 30, 2021 | -1.95 Mn |
| Mar 31, 2021 | -692,000.00 |